38 studies found for: Open Studies | "Platelet Aggregation Inhibitors"
What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
|23||Not yet recruiting||
Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention
Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)
Sexual Hormones and Haemostasis: Observations for Women Health
Effect of Ticagrelor on Endothelial Function
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Study of LC23-1306 in Healthy Male Subjects
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
† Indicates status has not been verified in more than two years